Cargando…
Avian antibodies (IgY) targeting spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibit receptor binding and viral replication
BACKGROUND: The global pandemic of Coronavirus infectious disease 2019 (COVID-19), caused by SARS-CoV-2, has plunged the world into both social and economic disarray, with vaccines still emerging and a continued paucity of personal protective equipment; the pandemic has also highlighted the potentia...
Autores principales: | Artman, Chad, Brumfield, Kyle D., Khanna, Sahil, Goepp, Julius |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162713/ https://www.ncbi.nlm.nih.gov/pubmed/34048457 http://dx.doi.org/10.1371/journal.pone.0252399 |
Ejemplares similares
-
Feasibility of Polyclonal Avian Immunoglobulins (IgY) as Prophylaxis against Human Norovirus Infection
por: Artman, Chad, et al.
Publicado: (2022) -
Feasibility of avian antibodies as prophylaxis against enterotoxigenic escherichia coli colonization
por: Brumfield, Kyle, et al.
Publicado: (2022) -
Avian IgY antibodies and their recombinant equivalents in research, diagnostics and therapy
por: Spillner, Edzard, et al.
Publicado: (2012) -
Generation of Chicken IgY against SARS-COV-2 Spike Protein and Epitope Mapping
por: Lu, Yan, et al.
Publicado: (2020) -
Avian antibodies (IgY) against Trypanosoma cruzi: Purification and characterization studies
por: Grando, Thirssa H., et al.
Publicado: (2017)